Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
12 EUR
8.80 B EUR
64.34 B EUR
29.01 M
About Roche Holding Ltd
Sector
Industry
CEO
Thomas Schinecker
Website
Headquarters
Basel
Founded
1896
ISIN
CH0012032113
FIGI
BBG01TT1NNJ5
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035Yield to maturity
5.56%
Maturity date
Jul 15, 2035
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054Yield to maturity
5.33%
Maturity date
Mar 8, 2054
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051Yield to maturity
5.25%
Maturity date
Dec 13, 2051
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054Yield to maturity
5.22%
Maturity date
Mar 8, 2054
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044Yield to maturity
5.17%
Maturity date
Nov 28, 2044
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034Yield to maturity
5.15%
Maturity date
Mar 8, 2034
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031Yield to maturity
5.07%
Maturity date
Mar 8, 2031
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029Yield to maturity
4.95%
Maturity date
Mar 8, 2029
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039Yield to maturity
4.91%
Maturity date
Mar 1, 2039
RH0H
Roche Holdings, Inc. 2.625% 15-MAY-2026Yield to maturity
4.80%
Maturity date
May 15, 2026
CHGCY5885612
Roche Holdings, Inc. 4.592% 09-SEP-2034Yield to maturity
4.56%
Maturity date
Sep 9, 2034
See all 1RO bonds
Curated watchlists where 1RO is featured.
Frequently Asked Questions
The current price of 1RO is 320 EUR — it has increased by 0.63% in the past 24 hours. Watch Roche Holding Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Roche Holding Ltd stocks are traded under the ticker 1RO.
1RO stock has fallen by −1.23% compared to the previous week, the month change is a 6.67% rise, over the last year Roche Holding Ltd has showed a 4.58% increase.
We've gathered analysts' opinions on Roche Holding Ltd future price: according to them, 1RO price has a max estimate of 470.68 EUR and a min estimate of 247.16 EUR. Watch 1RO chart and read a more detailed Roche Holding Ltd stock forecast: see what analysts think of Roche Holding Ltd and suggest that you do with its stocks.
1RO stock is 0.00% volatile and has beta coefficient of 1.52. Track Roche Holding Ltd stock price on the chart and check out the list of the most volatile stocks — is Roche Holding Ltd there?
Today Roche Holding Ltd has the market capitalization of 256.59 B, it has increased by 11.43% over the last week.
Yes, you can track Roche Holding Ltd financials in yearly and quarterly reports right on TradingView.
Roche Holding Ltd is going to release the next earnings report on Jan 29, 2026. Keep track of upcoming events with our Earnings Calendar.
1RO earnings for the last half-year are 11.86 EUR per share, whereas the estimation was 11.19 EUR, resulting in a 5.98% surprise. The estimated earnings for the next half-year are 9.36 EUR per share. See more details about Roche Holding Ltd earnings.
Roche Holding Ltd revenue for the last half-year amounts to 34.08 B EUR, despite the estimated figure of 33.04 B EUR. In the next half-year revenue is expected to reach 33.78 B EUR.
1RO net income for the last half-year is 7.93 B EUR, while the previous report showed 2.15 B EUR of net income which accounts for 269.20% change. Track more Roche Holding Ltd financial stats to get the full picture.
Yes, 1RO dividends are paid annually. The last dividend per share was 10.17 EUR. As of today, Dividend Yield (TTM)% is 3.24%. Tracking Roche Holding Ltd dividends might help you take more informed decisions.
Roche Holding Ltd dividend yield was 3.58% in 2024, and payout ratio reached 93.40%. The year before the numbers were 3.67% and 66.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 15, 2025, the company has 103.25 K employees. See our rating of the largest employees — is Roche Holding Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Roche Holding Ltd EBITDA is 23.52 B EUR, and current EBITDA margin is 35.81%. See more stats in Roche Holding Ltd financial statements.
Like other stocks, 1RO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Roche Holding Ltd stock right from TradingView charts — choose your broker and connect to your account.